-transparent.png){kind=logo}
Digitalis-like substance (DLS) was measured by Na-K-ATPase inhibitor (ATPI) activity and digitalis-like immunoreactivity (DLI) in 100 patients with type II diabetes. Hypertensive diabetic patients with a positive family history for hypertension had high ATPI levels compared with those patients with a negative family history for the disease. DLI level did not differ between groups. There was no significant difference in ATPI and DLI levels among three groups based on level of urinary albumin excretion. These data suggest that a circulating factor (or circulating factors) determined by ATPI may be linked with genetic factors in the development of hypertension, but not to the development of diabetic nephropathy.
S Okamoto, and
M Ikeda, and
T Morise, and
I Miyamori, and
R Takeda
January 1986,
Clinical and experimental hypertension. Part A, Theory and practice,
S Okamoto, and
M Ikeda, and
T Morise, and
I Miyamori, and
R Takeda
October 1996,
American journal of hypertension,
S Okamoto, and
M Ikeda, and
T Morise, and
I Miyamori, and
R Takeda
November 1998,
Neurochemistry international,
S Okamoto, and
M Ikeda, and
T Morise, and
I Miyamori, and
R Takeda
January 1987,
Klinische Wochenschrift,
S Okamoto, and
M Ikeda, and
T Morise, and
I Miyamori, and
R Takeda
August 1985,
European journal of clinical investigation,
S Okamoto, and
M Ikeda, and
T Morise, and
I Miyamori, and
R Takeda
December 1982,
Nature,
S Okamoto, and
M Ikeda, and
T Morise, and
I Miyamori, and
R Takeda
December 2006,
Cellular and molecular biology (Noisy-le-Grand, France),
S Okamoto, and
M Ikeda, and
T Morise, and
I Miyamori, and
R Takeda
January 1989,
The Canadian journal of cardiology,
S Okamoto, and
M Ikeda, and
T Morise, and
I Miyamori, and
R Takeda
July 1985,
Biochemical pharmacology,
S Okamoto, and
M Ikeda, and
T Morise, and
I Miyamori, and
R Takeda
January 1985,
Nauchnye doklady vysshei shkoly. Biologicheskie nauki,
